BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shan X, Li S, Sun B, Chen Q, Sun J, He Z, Luo C. Ferroptosis-driven nanotherapeutics for cancer treatment. Journal of Controlled Release 2020;319:322-32. [DOI: 10.1016/j.jconrel.2020.01.008] [Cited by in Crossref: 75] [Cited by in F6Publishing: 78] [Article Influence: 25.0] [Reference Citation Analysis]
Number Citing Articles
1 Han H, Li J, Santos HA. Recent advances in Fenton and Fenton-like reaction mediated nanoparticle in cancer therapy. Biomedical Technology 2023;3:40-51. [DOI: 10.1016/j.bmt.2022.12.004] [Reference Citation Analysis]
2 Ma G, Wang K, Pang X, Xu S, Gao Y, Liang Y, Yang J, Zhang X, Sun X, Dong J. Self-assembled nanomaterials for ferroptosis-based cancer theranostics. Biomater Sci 2023. [PMID: 36727583 DOI: 10.1039/d2bm02000a] [Reference Citation Analysis]
3 Xia Y, Zhang J, Liu G. A prospective strategy leveraging nanomedicine for cancer therapy: Pouring ferroptosis on apoptosis. Nano Today 2023;48:101740. [DOI: 10.1016/j.nantod.2022.101740] [Reference Citation Analysis]
4 Liu J, Li X, Chen J, Zhang X, Guo J, Gu J, Mei C, Xiao Y, Peng C, Liu J, Hu X, Zhang K, Li D, Zhou B. Arsenic-Loaded Biomimetic Iron Oxide Nanoparticles for Enhanced Ferroptosis-Inducing Therapy of Hepatocellular Carcinoma. ACS Appl Mater Interfaces 2023. [PMID: 36695492 DOI: 10.1021/acsami.2c14962] [Reference Citation Analysis]
5 Huang Y, Wang Y, Zheng T, Nie S, Wang Y, Shen H, Mo F. Graphene Fluorescent Nanoparticles Efficiently Targeting Cancer-Associated Fibroblasts and Pancreatic Cancer Cells.. [DOI: 10.21203/rs.3.rs-2445059/v1] [Reference Citation Analysis]
6 Huang L, Nie T, Jiang L, Chen Y, Zhou Y, Cai X, Zheng Y, Wang L, Wu J, Ying T. Acidity-Biodegradable Iridium-Coordinated Nanosheets for Amplified Ferroptotic Cell Death Through Multiple Regulatory Pathways. Adv Healthc Mater 2023;:e2202562. [PMID: 36610060 DOI: 10.1002/adhm.202202562] [Reference Citation Analysis]
7 Kicheeva AG, Sushko ES, Bondarenko LS, Kydralieva KA, Pankratov DA, Tropskaya NS, Dzeranov AA, Dzhardimalieva GI, Zarrelli M, Kudryasheva NS. Functionalized Magnetite Nanoparticles: Characterization, Bioeffects, and Role of Reactive Oxygen Species in Unicellular and Enzymatic Systems. Int J Mol Sci 2023;24. [PMID: 36674650 DOI: 10.3390/ijms24021133] [Reference Citation Analysis]
8 Sun X, Yang X, Wang J, Shang Y, Wang P, Sheng X, Liu X, Sun J, He Z, Zhang S, Luo C. Self-engineered lipid peroxidation nano-amplifier for ferroptosis-driven antitumor therapy. Chemical Engineering Journal 2023;451:138991. [DOI: 10.1016/j.cej.2022.138991] [Reference Citation Analysis]
9 Li S, Yang F, Wang Y, Du T, Hou X. Emerging nanotherapeutics for facilitating photodynamic therapy. Chemical Engineering Journal 2023;451:138621. [DOI: 10.1016/j.cej.2022.138621] [Reference Citation Analysis]
10 Dzeranov A, Bondarenko L, Pankratov D, Prokof‘ev M, Dzhardimalieva G, Jorobekova S, Tropskaya N, Telegina L, Kydralieva K. Iron Oxides Nanoparticles as Components of Ferroptosis-Inducing Systems: Screening of Potential Candidates. Magnetochemistry 2022;9:3. [DOI: 10.3390/magnetochemistry9010003] [Reference Citation Analysis]
11 Zhang X, Ge H, Ma Y, Song L, Ma Y, Tian G, Wang L, Meng Q, Sun X. Engineered Anti-cancer Nanomedicine for Synergistic Ferroptosis-Immunotherapy. Chemical Engineering Journal 2022. [DOI: 10.1016/j.cej.2022.140688] [Reference Citation Analysis]
12 Li J, Zhou Y, Liu J, Yang X, Zhang K, Lei L, Hu H, Zhang H, Ouyang L, Gao H. Metal-phenolic networks with ferroptosis to deliver NIR-responsive CO for synergistic therapy. J Control Release 2022;352:313-27. [PMID: 36272661 DOI: 10.1016/j.jconrel.2022.10.025] [Reference Citation Analysis]
13 Bilbao‐asensio M, Ruiz‐de‐angulo A, Arguinzoniz AG, Cronin J, Llop J, Zabaleta A, Michue‐seijas S, Sosnowska D, Arnold JN, Mareque‐rivas JC. Redox‐Triggered Nanomedicine via Lymphatic Delivery: Inhibition of Melanoma Growth by Ferroptosis Enhancement and a Pt(IV)‐Prodrug Chemoimmunotherapy Approach. Advanced Therapeutics 2022. [DOI: 10.1002/adtp.202200179] [Reference Citation Analysis]
14 Agnihotri TG, Gomte SS, Jain A. Emerging theranostics to combat cancer: a perspective on metal-based nanomaterials. Drug Dev Ind Pharm 2022;48:585-601. [PMID: 36448770 DOI: 10.1080/03639045.2022.2153862] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Yao H, Qiao P, Zhu Z, Sun F, Zhou H, Geng M, Du B. Multiple Strikes Achieve Remarkable Tumor-Inhibition Efficiency via Multi-mechanism Combination. ACS Biomater Sci Eng 2022. [PMID: 36166484 DOI: 10.1021/acsbiomaterials.2c00778] [Reference Citation Analysis]
16 Morrow JP, Mazrad ZAI, Bush AI, Kempe K. Poly(2-oxazoline) - Ferrostatin-1 drug conjugates inhibit ferroptotic cell death. J Control Release 2022;350:193-203. [PMID: 35944752 DOI: 10.1016/j.jconrel.2022.08.004] [Reference Citation Analysis]
17 Ren M, Zheng X, Gao H, Jiang A, Yao Y, He W. Nanomedicines Targeting Metabolism in the Tumor Microenvironment. Front Bioeng Biotechnol 2022;10:943906. [DOI: 10.3389/fbioe.2022.943906] [Reference Citation Analysis]
18 Zhang S, Zhang J, Fan X, Liu H, Zhu M, Yang M, Zhang X, Zhang H, Yu F. Ionizing Radiation-Induced Ferroptosis Based on Nanomaterials. IJN 2022;Volume 17:3497-507. [DOI: 10.2147/ijn.s372947] [Reference Citation Analysis]
19 Wang J, Yang W, He X, Zhang Z, Zheng X. Assembling p53 Activating Peptide With CeO2 Nanoparticle to Construct a Metallo-Organic Supermolecule Toward the Synergistic Ferroptosis of Tumor. Front Bioeng Biotechnol 2022;10:929536. [DOI: 10.3389/fbioe.2022.929536] [Reference Citation Analysis]
20 Ma X, Li SJ, Liu Y, Zhang T, Xue P, Kang Y, Sun ZJ, Xu Z. Bioengineered nanogels for cancer immunotherapy. Chem Soc Rev 2022;51:5136-74. [PMID: 35666131 DOI: 10.1039/d2cs00247g] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
21 Wang D, Tang L, Zhang Y, Ge G, Jiang X, Mo Y, Wu P, Deng X, Li L, Zuo S, Yan Q, Zhang S, Wang F, Shi L, Li X, Xiang B, Zhou M, Liao Q, Guo C, Zeng Z, Xiong W, Gong Z. Regulatory pathways and drugs associated with ferroptosis in tumors. Cell Death Dis 2022;13:544. [PMID: 35688814 DOI: 10.1038/s41419-022-04927-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
22 Li L, Wang B, Zhang Q, Song P, Jiang T, Zhao X. Hypoxia responsive fucoidan-based micelles for oxidative stress-augmented chemotherapy. European Polymer Journal 2022. [DOI: 10.1016/j.eurpolymj.2022.111340] [Reference Citation Analysis]
23 Zhang C, Yu J, Yang C, Shang S, Lv X, Cui B, Hua F. Crosstalk between ferroptosis and stress—Implications in cancer therapeutic responses. Cancer Innovation 2022;1:92-113. [DOI: 10.1002/cai2.7] [Reference Citation Analysis]
24 Zhu L, Meng D, Wang X, Chen X. Ferroptosis-Driven Nanotherapeutics to Reverse Drug Resistance in Tumor Microenvironment. ACS Appl Bio Mater 2022. [PMID: 35614872 DOI: 10.1021/acsabm.2c00199] [Reference Citation Analysis]
25 Wu F, Huang C, Sun B, Zhu Z, Cheng W, Chen Y, Liao C, Xu R, Maimaititu’ersun M, Zhou N, Han F, Cai Z, Jiang H. H 2 O 2 Self-Supplementing and GSH-Depleting Nanoreactors Based on MoO 3– x @Fe 3 O 4 -GOD-PVP for Photothermally Reinforced Nanocatalytic Cancer Therapy at the Second Near-Infrared Biowindow. ACS Sustainable Chem Eng 2022;10:6346-57. [DOI: 10.1021/acssuschemeng.2c00964] [Reference Citation Analysis]
26 Qiao L, Yang H, Shao X, Yin Q, Fu X, Wei Q. Research Progress on Nanoplatforms and Nanotherapeutic Strategies in Treating Glioma. Mol Pharmaceutics. [DOI: 10.1021/acs.molpharmaceut.1c00856] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Sun F, Peng Y, Li Y, Xu M, Cai T. Fenton-reaction-triggered metabolism of acetaminophen for enhanced cancer therapy. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.05.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Si C, Zhou X, Deng J, Ye S, Kong L, Zhang B, Wang W. Role of ferroptosis in gastrointestinal tumors: From mechanisms to therapies. Cell Biol Int 2022. [PMID: 35476364 DOI: 10.1002/cbin.11804] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Zhu C, Wang Y, Li Z, Sun W, Jiang BP, Shen XC. Metallopolysaccharide-Based Smart Nanotheranostic for Imaging-Guided Precise Phototherapy and Sequential Enzyme-Activated Ferroptosis. Biomacromolecules 2022. [PMID: 35404583 DOI: 10.1021/acs.biomac.2c00018] [Reference Citation Analysis]
30 Liu P, Shi X, Peng Y, Hu J, Ding J, Zhou W. Anti-PD-L1 DNAzyme Loaded Photothermal Mn2+ /Fe3+ Hybrid Metal-Phenolic Networks for Cyclically Amplified Tumor Ferroptosis-Immunotherapy. Adv Healthc Mater 2022;11:e2102315. [PMID: 34841741 DOI: 10.1002/adhm.202102315] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
31 Bano I, Horky P, Abbas SQ, Majid M, Bilal AHM, Ali F, Behl T, Hassan SSU, Bungau S. Ferroptosis: A New Road towards Cancer Management. Molecules 2022;27:2129. [PMID: 35408533 DOI: 10.3390/molecules27072129] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
32 Shi Z, Zheng J, Tang W, Bai Y, Zhang L, Xuan Z, Sun H, Shao C. Multifunctional Nanomaterials for Ferroptotic Cancer Therapy. Front Chem 2022;10:868630. [DOI: 10.3389/fchem.2022.868630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Komiyama M, Shigi N, Ariga K. DNA‐Based Nanoarchitectures as Eminent Vehicles for Smart Drug Delivery Systems. Adv Funct Materials. [DOI: 10.1002/adfm.202200924] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
34 Li J, Luo G, Zhang C, Long S, Guo L, Yang G, Wang F, Zhang L, Shi L, Fu Y, Zhang Y. In situ injectable hydrogel-loaded drugs induce anti-tumor immune responses in melanoma immunochemotherapy. Materials Today Bio 2022;14:100238. [DOI: 10.1016/j.mtbio.2022.100238] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
35 Guo R, Wang S, Zhao L, Zong Q, Li T, Ling G, Zhang P. Engineered nanomaterials for synergistic photo-immunotherapy. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121425] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
36 Chen Q, Xu S, Liu S, Wang Y, Liu G. Emerging nanomedicines of paclitaxel for cancer treatment. J Control Release 2022;342:280-94. [PMID: 35016919 DOI: 10.1016/j.jconrel.2022.01.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
37 Ji B, Wei M, Yang B. Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy. Theranostics 2022;12:434-58. [PMID: 34987658 DOI: 10.7150/thno.67300] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 17.0] [Reference Citation Analysis]
38 Li X, Song Q, Zhou T, Chen H, Nan W, Xie L, Wang H, Zhang Q, Hao Y. Facile fabrication of a biodegradable multi-hollow iron phosphate nanoplatform for tumor-specific nanocatalytic therapy and chemotherapy. Biomater Sci 2022;10:6818-6827. [DOI: 10.1039/d2bm01033j] [Reference Citation Analysis]
39 Chen S, Zhu JY, Zang X, Zhai YZ. The Emerging Role of Ferroptosis in Liver Diseases. Front Cell Dev Biol 2021;9:801365. [PMID: 34970553 DOI: 10.3389/fcell.2021.801365] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
40 Han H, Bártolo R, Li J, Shahbazi M, Santos HA. Biomimetic platelet membrane-coated nanoparticles for targeted therapy. European Journal of Pharmaceutics and Biopharmaceutics 2022;172:1-15. [DOI: 10.1016/j.ejpb.2022.01.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
41 Xu J, Zhang H, Zhang Y, Zhang X, Wang T, Hong S, Wei W, Zhao T, Fang W. Controllable synthesis of variable-sized magnetic nanocrystals self-assembled into porous nanostructures for enhanced cancer chemo-ferroptosis therapy and MR imaging. Nanoscale Adv . [DOI: 10.1039/d1na00767j] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Tang Z, Huang Z, Huang Y, Chen Y, Huang M, Liu H, Ye QA, Zhao J, Jia B. Ferroptosis: The Silver Lining of Cancer Therapy. Front Cell Dev Biol 2021;9:765859. [PMID: 34912804 DOI: 10.3389/fcell.2021.765859] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
43 Wang Y, Luo C, Zhou S, Wang X, Zhang X, Li S, Zhang S, Wang S, Sun B, He Z, Sun J. Investigating the crucial roles of aliphatic tails in disulfide bond-linked docetaxel prodrug nanoassemblies. Asian J Pharm Sci 2021;16:643-52. [PMID: 34849169 DOI: 10.1016/j.ajps.2021.02.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
44 Li S, Yang F, Sun X, Wang Y, Zhang X, Zhang S, Zhang H, Kan Q, Sun J, He Z, Luo C. Precisely engineering a carrier-free hybrid nanoassembly for multimodal DNA damage-augmented photodynamic therapy. Chemical Engineering Journal 2021;426:130838. [DOI: 10.1016/j.cej.2021.130838] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
45 Qi A, Wang C, Ni S, Meng Y, Wang T, Yue Z, Yang K, Li Y, Cheng Z, Guo P, Zhang C. Intravesical Mucoadhesive Hydrogel Induces Chemoresistant Bladder Cancer Ferroptosis through Delivering Iron Oxide Nanoparticles in a Three-Tier Strategy. ACS Appl Mater Interfaces 2021. [PMID: 34714617 DOI: 10.1021/acsami.1c14944] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
46 Zeng N, Ma L, Cheng Y, Xia Q, Li Y, Chen Y, Lu Z, Lu Q, Jiang F, Luo D. Construction of a Ferroptosis-Related Gene Signature for Predicting Survival and Immune Microenvironment in Melanoma Patients. Int J Gen Med 2021;14:6423-38. [PMID: 34675611 DOI: 10.2147/IJGM.S327348] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
47 Feng Z, Chen P, Li K, Lou J, Wu Y, Li T, Peng C. A Novel Ferroptosis-Related Gene Signature Predicts Recurrence in Patients With Pancreatic Ductal Adenocarcinoma. Front Mol Biosci 2021;8:650264. [PMID: 34631790 DOI: 10.3389/fmolb.2021.650264] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Liang Y, Zhang L, Peng C, Zhang S, Chen S, Qian X, Luo W, Dan Q, Ren Y, Li Y, Zhao B. Tumor microenvironments self-activated nanoscale metal-organic frameworks for ferroptosis based cancer chemodynamic/photothermal/chemo therapy. Acta Pharm Sin B 2021;11:3231-43. [PMID: 34729312 DOI: 10.1016/j.apsb.2021.01.016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 8.5] [Reference Citation Analysis]
49 Xu C, Xiao Z, Wang J, Lai H, Zhang T, Guan Z, Xia M, Chen M, Ren L, He Y, Gao Y, Zhao C. Discovery of a Potent Glutathione Peroxidase 4 Inhibitor as a Selective Ferroptosis Inducer. J Med Chem 2021;64:13312-26. [PMID: 34506134 DOI: 10.1021/acs.jmedchem.1c00569] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
50 Shan X, Zhang X, Wang C, Zhao Z, Zhang S, Wang Y, Sun B, Luo C, He Z. Molecularly engineered carrier-free co-delivery nanoassembly for self-sensitized photothermal cancer therapy. J Nanobiotechnology 2021;19:282. [PMID: 34544447 DOI: 10.1186/s12951-021-01037-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
51 Gao J, Luo T, Wang J. Gene interfered-ferroptosis therapy for cancers. Nat Commun 2021;12:5311. [PMID: 34493724 DOI: 10.1038/s41467-021-25632-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 11.0] [Reference Citation Analysis]
52 Li D, Ren J, Li J, Zhang Y, Lou Y, Zhu J, Liu P, Chen Y, Yu Z, Zhao L, Zhang L, Chen X, Zhu J, Tao J. Ferroptosis-apoptosis combined anti-melanoma immunotherapy with a NIR-responsive upconverting mSiO2 photodynamic platform. Chemical Engineering Journal 2021;419:129557. [DOI: 10.1016/j.cej.2021.129557] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
53 Peng C, Fu X, Wang K, Chen L, Luo B, Huang N, Luo Y, Chen W. Dauricine alleviated secondary brain injury after intracerebral hemorrhage by upregulating GPX4 expression and inhibiting ferroptosis of nerve cells. Eur J Pharmacol 2021;:174461. [PMID: 34469757 DOI: 10.1016/j.ejphar.2021.174461] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
54 Xu C, Chen H. A Ferroptosis-Related Gene Model Predicts Prognosis and Immune Microenvironment for Cutaneous Melanoma. Front Genet 2021;12:697043. [PMID: 34447410 DOI: 10.3389/fgene.2021.697043] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
55 Yin Y, Jiang T, Hao Y, Zhang J, Li W, Hao Y, He W, Song Y, Feng Q, Ma W. Cascade catalytic nanoplatform based on ions interference strategy for calcium overload therapy and ferroptosis. Int J Pharm 2021;606:120937. [PMID: 34310960 DOI: 10.1016/j.ijpharm.2021.120937] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
56 Zafar H, Raza F, Ma S, Wei Y, Zhang J, Shen Q. Recent progress on nanomedicine-induced ferroptosis for cancer therapy. Biomater Sci 2021;9:5092-115. [PMID: 34160488 DOI: 10.1039/d1bm00721a] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
57 Liu L, Li L, Li M, Luo Z. Autophagy-Dependent Ferroptosis as a Therapeutic Target in Cancer. ChemMedChem 2021. [PMID: 34110079 DOI: 10.1002/cmdc.202100334] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
58 Chen H, Yan Z, Wu S, Li F. A glutathione-responsive polyphenol - Constructed nanodevice for double roles in apoptosis and ferroptosis. Colloids Surf B Biointerfaces 2021;205:111902. [PMID: 34107442 DOI: 10.1016/j.colsurfb.2021.111902] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
59 Li S, Liu Y, Li J, Zhao X, Yu D. Mechanisms of Ferroptosis and Application to Head and Neck Squamous Cell Carcinoma Treatments. DNA Cell Biol 2021;40:720-32. [PMID: 33979530 DOI: 10.1089/dna.2021.0023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
60 Fei W, Zhang Y, Ye Y, Li C, Yao Y, Zhang M, Li F, Zheng C. Bioactive metal-containing nanomaterials for ferroptotic cancer therapy. J Mater Chem B 2020;8:10461-73. [PMID: 33231601 DOI: 10.1039/d0tb02138e] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
61 Zhang S, Wang Z, Kong Z, Wang Y, Zhang X, Sun B, Zhang H, Kan Q, He Z, Luo C, Sun J. Photosensitizer-driven nanoassemblies of homodimeric prodrug for self-enhancing activation and synergistic chemo-photodynamic therapy. Theranostics 2021;11:6019-32. [PMID: 33897896 DOI: 10.7150/thno.59065] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
62 Zong L, Wang H, Hou X, Fu L, Wang P, Xu H, Yu W, Dai Y, Qiao Y, Wang X, Yuan Q, Pang X, Han G, Pu X. A novel GSH-triggered polymeric nanomicelles for reversing MDR and enhancing antitumor efficiency of hydroxycamptothecin. Int J Pharm 2021;600:120528. [PMID: 33781880 DOI: 10.1016/j.ijpharm.2021.120528] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
63 Liu P, Shi X, Zhong S, Peng Y, Qi Y, Ding J, Zhou W. Metal-phenolic networks for cancer theranostics. Biomater Sci 2021;9:2825-49. [PMID: 33688863 DOI: 10.1039/d0bm02064h] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
64 Wang Y, Li S, Wang X, Chen Q, He Z, Luo C, Sun J. Smart transformable nanomedicines for cancer therapy. Biomaterials 2021;271:120737. [PMID: 33690103 DOI: 10.1016/j.biomaterials.2021.120737] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 13.0] [Reference Citation Analysis]
65 Lou J, Zhou Y, Feng Z, Ma M, Yao Y, Wang Y, Deng Y, Wu Y. Caspase-Independent Regulated Necrosis Pathways as Potential Targets in Cancer Management. Front Oncol 2020;10:616952. [PMID: 33665167 DOI: 10.3389/fonc.2020.616952] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
66 Liu X, Zhu X, Qi X, Meng X, Xu K. Co-Administration of iRGD with Sorafenib-Loaded Iron-Based Metal-Organic Framework as a Targeted Ferroptosis Agent for Liver Cancer Therapy. Int J Nanomedicine 2021;16:1037-50. [PMID: 33603367 DOI: 10.2147/IJN.S292528] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 10.5] [Reference Citation Analysis]
67 Cheng Y, Xie Y, Chen Y, Liu X. Epigenetic Regulation and Nonepigenetic Mechanisms of Ferroptosis Drive Emerging Nanotherapeutics in Tumor. Oxid Med Cell Longev 2021;2021:8854790. [PMID: 33574983 DOI: 10.1155/2021/8854790] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
68 Zhang X, Xiong J, Wang K, Yu H, Sun B, Ye H, Zhao Z, Wang N, Wang Y, Zhang S, Zhao W, Zhang H, He Z, Luo C, Sun J. Erythrocyte membrane-camouflaged carrier-free nanoassembly of FRET photosensitizer pairs with high therapeutic efficiency and high security for programmed cancer synergistic phototherapy. Bioact Mater 2021;6:2291-302. [PMID: 33553816 DOI: 10.1016/j.bioactmat.2021.01.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 14.0] [Reference Citation Analysis]
69 Ma H, Wang X, Zhang W, Li H, Zhao W, Sun J, Yang M. Melatonin Suppresses Ferroptosis Induced by High Glucose via Activation of the Nrf2/HO-1 Signaling Pathway in Type 2 Diabetic Osteoporosis. Oxid Med Cell Longev 2020;2020:9067610. [PMID: 33343809 DOI: 10.1155/2020/9067610] [Cited by in Crossref: 75] [Cited by in F6Publishing: 93] [Article Influence: 25.0] [Reference Citation Analysis]
70 Tang X, Wang Z, Zhu Y, Xiao H, Xiao Y, Cui S, Lin B, Yang K, Liu H. Hypoxia-activated ROS burst liposomes boosted by local mild hyperthermia for photo/chemodynamic therapy. Journal of Controlled Release 2020;328:100-11. [DOI: 10.1016/j.jconrel.2020.08.035] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 5.7] [Reference Citation Analysis]
71 Guo X, Liu F, Deng J, Dai P, Qin Y, Li Z, Wang B, Fan A, Wang Z, Zhao Y. Electron-Accepting Micelles Deplete Reduced Nicotinamide Adenine Dinucleotide Phosphate and Impair Two Antioxidant Cascades for Ferroptosis-Induced Tumor Eradication. ACS Nano 2020;14:14715-30. [PMID: 33156626 DOI: 10.1021/acsnano.0c00764] [Cited by in Crossref: 58] [Cited by in F6Publishing: 64] [Article Influence: 19.3] [Reference Citation Analysis]
72 Liu R, Rong G, Liu Y, Huang W, He D, Lu R. Delivery of apigenin-loaded magnetic Fe2O3/Fe3O4@mSiO2 nanocomposites to A549 cells and their antitumor mechanism. Mater Sci Eng C Mater Biol Appl 2021;120:111719. [PMID: 33545870 DOI: 10.1016/j.msec.2020.111719] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
73 Castillo RR, Vallet-Regí M. Emerging Strategies in Anticancer Combination Therapy Employing Silica-Based Nanosystems. Biotechnol J 2021;16:e1900438. [PMID: 33079451 DOI: 10.1002/biot.201900438] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
74 Wang B, Zhang X, Wang Z, Shi D. Ferroptotic nanomaterials enhance cancer therapy via boosting Fenton-reaction. Journal of Drug Delivery Science and Technology 2020;59:101883. [DOI: 10.1016/j.jddst.2020.101883] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
75 Wu Y, Yu C, Luo M, Cen C, Qiu J, Zhang S, Hu K. Ferroptosis in Cancer Treatment: Another Way to Rome. Front Oncol 2020;10:571127. [PMID: 33102227 DOI: 10.3389/fonc.2020.571127] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 15.7] [Reference Citation Analysis]
76 Li J, Zhao J, Chen Y, Zheng Y, Zhou L, Zhao J, Liu Y, Liu X, Wang S. Design and therapeutic application of sodium alginate-based hydrogel with biodegradability and catalytic activity. Sci China Technol Sci 2020;63:2403-12. [DOI: 10.1007/s11431-020-1623-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
77 Li S, Shan X, Wang Y, Chen Q, Sun J, He Z, Sun B, Luo C. Dimeric prodrug-based nanomedicines for cancer therapy. J Control Release 2020;326:510-22. [PMID: 32721523 DOI: 10.1016/j.jconrel.2020.07.036] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 13.7] [Reference Citation Analysis]
78 Wu T, Liang X, Liu X, Li Y, Wang Y, Kong L, Tang M. Induction of ferroptosis in response to graphene quantum dots through mitochondrial oxidative stress in microglia. Part Fibre Toxicol 2020;17:30. [PMID: 32652997 DOI: 10.1186/s12989-020-00363-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 9.3] [Reference Citation Analysis]
79 Wu X, Liu C, Li Z, Gai C, Ding D, Chen W, Hao F, Li W. Regulation of GSK3β/Nrf2 signaling pathway modulated erastin-induced ferroptosis in breast cancer. Mol Cell Biochem 2020;473:217-28. [PMID: 32642794 DOI: 10.1007/s11010-020-03821-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 9.0] [Reference Citation Analysis]
80 Mu M, Wang Y, Zhao S, Li X, Fan R, Mei L, Wu M, Zou B, Zhao N, Han B, Guo G. Engineering a pH/Glutathione-Responsive Tea Polyphenol Nanodevice as an Apoptosis/Ferroptosis-Inducing Agent. ACS Appl Bio Mater 2020;3:4128-38. [DOI: 10.1021/acsabm.0c00225] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
81 Yang F, Zhao Z, Sun B, Chen Q, Sun J, He Z, Luo C. Nanotherapeutics for Antimetastatic Treatment. Trends Cancer 2020;6:645-59. [PMID: 32448754 DOI: 10.1016/j.trecan.2020.05.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
82 Gao J, Luo T, Lin N, Wang J. Gene interfered-ferroptosis therapy of cancer.. [DOI: 10.1101/2020.04.19.048785] [Reference Citation Analysis]
83 Chen Y, Shan X, Luo C, He Z. Emerging nanoparticulate drug delivery systems of metformin. J Pharm Investig 2020;50:219-30. [DOI: 10.1007/s40005-020-00480-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 6.7] [Reference Citation Analysis]
84 Hu Z, Wang S, Dai Z, Zhang H, Zheng X. A novel theranostic nano-platform (PB@FePt–HA- g -PEG) for tumor chemodynamic–photothermal co-therapy and triple-modal imaging (MR/CT/PI) diagnosis. J Mater Chem B 2020;8:5351-60. [DOI: 10.1039/d0tb00708k] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]